Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance

BACKGROUND: Two manufacturers, Maxim Biomedical and Sedia Biosciences Corporation, supply CDC-approved versions of the HIV-1 Limiting Antigen Avidity EIA (LAg) for detecting ‘recent’ HIV infection in cross-sectional incidence estimation. This study assesses and compares the performance of the two as...

Descripción completa

Detalles Bibliográficos
Autores principales: Sempa, Joseph B., Welte, Alex, Busch, Michael P., Hall, Jake, Hampton, Dylan, Facente, Shelley N., Keating, Sheila M., Marson, Kara, Parkin, Neil, Pilcher, Christopher D., Murphy, Gary, Grebe, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660077/
https://www.ncbi.nlm.nih.gov/pubmed/31348809
http://dx.doi.org/10.1371/journal.pone.0220345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660077/
https://www.ncbi.nlm.nih.gov/pubmed/31348809
http://dx.doi.org/10.1371/journal.pone.0220345

Ejemplares similares